INFORMATION BY CANCER TYPE

Kidney

Expert Gives Updates on Kidney and Bladder Cancer
BY Gina Columbus

Sumanta Kumar Pal, M.D., associate professor, Department of Medical Oncology, City of Hope, covered the scope of exciting genitourinary cancer data presented at the 2017 ESMO Congress, with a sharp focus on the CABOSUN and CheckMate-214 trials.
A Wave of Optimism for New Kidney Cancer Drugs
BY CHRISTIN MELTON, ELS
The latest drugs for advanced kidney cancer are stirring optimism.
First Biosimilar to Treat Cancer Gets FDA Approval
BY Jason Harris
The Food and Drug Administration approved the first ever biosimilar to treat a variety of cancers.
 
Less Pain, Faster Healing With Robotic Surgery for Kidney Cancer
BY Danielle Bucco
In an interview with CURE, Badani, a professor of Urology at Mount Sinai Hospital, discusses the benefits of robotic surgery in RCC. 
 
Cabometyx's Benefit in Kidney Cancer Is Confirmed
BY Jason Harris

Cabometyx had better progression-free survival rates than Sutent (sunitinib) for certain patients with renal cell carcinoma. 

Duo Falls Short in Treating Advanced Kidney Cancer
BY Jason Harris
Progression-free survival (PFS) was not significantly improved with the combination of dalantercept plus Inlyta (axitinib) in patients with advanced renal cell carcinoma (RCC) compared with placebo, according to the results from the phase 2 DART trial.
Promising Combination Moves Into Kidney Cancer
BY Jason M. Broderick
Bavencio and Inlyta together produced a promising response for some patients with renal cell carcinoma. 
Expert Stresses Significance of Genetic Differences in Kidney Cancer
BY Angelica Welch
There are 16 known genes that cause kidney cancer and at least 13 different types of inherited kidney cancer, emphasizing the need to understand genetic differences between these disease.
Metastatic Kidney Cancer or a Separate Lung Cancer? Expert Urges Patients, Doctors to Learn the Difference
BY Brielle Urciuoli
James Brugarolas, M.D., Ph.D., discusses the importance of spotting the difference between a metastatic kidney cancer lesion and a separate lung cancer. The difference can save patients' lives.
Expert Weighs in on Promising New Options for Frontline Kidney Cancer
BY Angelica Welch
David McDermott, M.D. discusses new advances made to treat kidney cancer. 
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Kidney CURE discussion group.
Search Cancer Drugs & Terms
x
//For side ad protocol